Director, Clinical and Translational Cancer Prevention Program
Pleural Mesothelioma, Lung Cancer, Oropharyngeal Cancer
Yonsei University, College of Medicine in Seoul, Korea
Chicago's Cook County Hospital
Bio
Dong M. Shin, M.D., is director of the Clinical and Translational Cancer Prevention Program as well as professor of hematology and oncology at Emory University’s Winship Cancer Institute in Atlanta, Georgia.
Shin’s primary research focused on head, neck and lung cancers with a special interest in the rare cancer mesothelioma. He has worked with developing biomarkers for all of these conditions. For mesothelioma, the detection of specific biomarkers has become a new way to diagnose the cancer.
During his research, Shin found positive results by treating pleural mesothelioma with a combination of chemotherapy and vitamin supplementation. In a 2003 study conducted by Shin and other researchers, patients who received pemetrexed with folic acid and vitamin B12 survived an average of five months longer than those who received treatment with pemetrexed only.
In a Phase III clinical trial on pleural mesothelioma in 2005, Shin was the lead investigator in evaluating the efficacy and safety of using vorinostat, an experimental drug. Vorinostat is believed to stop the growth of cancerous cells.
Before joining the Emory Winship Cancer Institute in 2003, Shin held faculty positions at the University of Pittsburgh and MD Anderson Cancer Center in Houston.
Shin remains focused on treating and preventing head, neck, lung and mesothelioma cancer. He is certified by the American Board of Internal Medicine in Internal Medicine and Medical Oncology.
-
02/10/2012 -
Many of the high-profile mesothelioma advocates and leaders in the anti-asbestos fight will gather this weekend in South Florida for the two-day Miles ..
-
02/10/2012 -
Not only is February marked by Valentine's Day, President's Day and Black History Month, but it is also National Cancer Prevention Month.
For the n ..
-
02/09/2012 -
A routine inspection at California State University Northridge by its Environmental Health and Safety Department showed just how prevalent toxic asbes ..
© 2012 The Mesothelioma Center |
Last Modified Thursday, February 9th, 2012 | Disclaimer | Privacy Policy |
The information provided by The Mesothelioma Center is not a substitute for professional medical advice, diagnosis or treatment.
Sponsored by a law firm concentrating in asbestos litigation, The Peterson Firm, LLP with offices at 1350 Connecticut Ave, NW, Fifth Floor, Washington DC 20036.
